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 In the era of patient participation in health care decision making, we know surprisingly 
little about the ways in which treatment recommendations are made, the contexts that shape their 
formulation and the consequences of these formulations. There is a growing body of 
conversation analytic work concerned with how treatment decisions are reached in a range of 
clinical settings, including pediatrics (Stivers, 2007); general practice (Koenig, 2011); oncology 
clinics (Collins, Drew, Watt, & Entwistle, 2005; Costello & Robert, 2001); and a range of others 
(Hudak, Clark, & Raymond, 2011; Pilnick, 2008; Quirk, Chaplin, Lelliott, & Seale, 2012; 
Toerien, Shaw, & Reuber, 2013). Yet this work remains quite narrow in scope and is scattered 
across a variety of medical specialties that are far from uniform. This lack of systematic 
examination of treatment recommendation action, design, and reception inhibits comparative 
work whether by national context, medical specialty, or patient demographics.  
 This project is part of a tradition that blends conversation analytic work with interaction 
coding in order to facilitate comparisons or investigations that are otherwise impossible. 
Comparisons can be quantitative such as comparing questioning across different historical time 
periods (Clayman, Elliott, Heritage, & McDonald, 2006) or comparing speed of turn taking 
across languages and cultures (Stivers et al., 2009). However, comparisons can also remain 
qualitative. Regardless of whether the comparison is quantitative or qualitative, conversation 
analysis requires a collection of particular behaviors. This means that rules are necessary to 
discriminate what "counts" as a particular communicative behavior (Dingemanse & Enfield, 
2015). This becomes all the more critical when attempting to understand behaviors across 
national contexts and across medical specialties where we can expect big differences in 
recommendations. 
 This special issue is organized around a systematic collective investigation of how 
recommendations for medications are responded to and made. This establishes a framework 
within which we are beginning to examine how recommendations are shaped by whether or not 
the recommendation took place in primary vs. secondary care, in the US vs. the UK, and whether 
the medication was over-the-counter vs. by prescription. The five core contributions to this 
special issue address these three main topics: 1) what constitutes a recommendation for new 
medication? 2) how are recommendations designed actions and formulated?, and 3) how do 
patients respond to these recommendations?  
 First, in terms of what constitutes a medication recommendation, we were very broad. 
The general goal was to identify utterances that patients typically treated as clear 
recommendations. In order to ascertain the parameters for these types of recommendation, 
preliminary work across the range of different data sets was done to inform the final coding 
scheme. In line with this, we included vague and general recommendations "for treatment" or for 
"something" since patients typically treat these as recommendations. We included medication 
recommendations that were for pre-specified periods of time (e.g., 7 days), 'as needed' 
medication recommendations (e.g., cough medicine), and recommendations that were prescribed 
for indefinite periods (e.g., cholesterol medication). Finally, we included in our definition of 
medication both over-the-counter recommendations and prescription medications. 
 Our pilot analyses suggested the exclusion of a variety of medical recommendations on 
the grounds that they would introduce more variation than we could hope to understand at this 
point in time. Thus, for purposes of these analyses, we excluded five types of recommendations. 
First, we did not include any non-medication recommendations -- referrals, medical tests, and 
treatment such as massage, icing, bandages, wraps etc. Relatedly, we excluded medication 
recommendations initiated by the patient through, for instance, a request. Recommendations that 
were nth recommendations for the same medication in the same visit were also excluded, as were 
dosage changes to the same medication. We also excluded recommendations that were 
"contingent" on the future presence of symptoms or other factors not currently present. Thus 
recommendations for medication "if you start having headaches" in a patient who has not 
reported any headaches would not have been included. Finally, utterances such as "Have you 
tried Robitussin?" were not included as recommendations because these were rarely treated as 
such and were normally understood as preliminary to actual recommendations (Barnes, in press). 
 With these concepts and issues in mind, we had a goal to identify 120 encounters that 
contained at least one recommendation for a new medication in each clinical context. However, 
in specialty care there were often no recommendations for new medications, so the data sets were 
not necessarily large enough to identify this many. In the end, we identified 794 
recommendations for medication of which, 62% were from the UK primary care data and 38% 
were from US data. Of the UK data, 80% were from primary care. The remainder were from 
specialty care practices. Within a central focus on how treatment recommendations are presented 
to patients, and whether and how patients received them, each article in this issue examines a 
subset of the data focusing either on a particular type of medical recommendation and its 
implementation within a medical specialty and/or cross-national comparisons within primary 
care. 
 The dimensions on which our coding scheme focused are summarized in Table 1. 
Although this special issue will not explore all of these, we provide them as background because 
they nonetheless informed our thinking about treatment recommendation delivery and reception.  
Place Table 1 about here 
 
Interactional coding categories 
 Our coding scheme is squarely focused on interactional aspects of the treatment 
recommendation turn and its reception, together with a range of non-interactional variables 
itemized below under "Covariates." Our codes were informed by both prior work by the authors 
and pilot work examining a smaller subset of our data to identify the dimensions of variation 
present in the data. Seven aspects of the treatment recommendation sequence were ultimately 
identified and coded.  
 
1) We identified the main social actions being relied on by physicians to present 
recommendations. These actions differ broadly in terms of who is being treated as the instigator 
of the recommendation; who is treated as the decision maker; and highlights different aspects of 
the recommendation in terms of whether it is, for instance, optional or speculative. 
 
2) Within each social action type, we assessed the strength of the physician's endorsement of 
the medication. We did this by holistically rating the recommendation as strong to weak, relative 
to other recommendations within the same action type.  
 
3) We examined whether or not patients were presented with recommendations for multiple 
medications including situations in which patients are presented with a list of medications 
indicating that patients can choose from any in a class (e.g., "I'd recommend X, Y, or Z or 
whatever your favorite cough medicine is" where each is the name of a cough medicine) and 
fixed alternatives for patients to choose among. 
 
4) We coded how the physician's reference to the medication is done. We identified four 
possibilities: by drug name, drug class, a pronominal reference or a "generic" reference (e.g., 
"some treatment" or "something").  
 
5) Some of the recommendations physicians made invoked a reference to partnership with the 
patient through the invocation of "we" or "us." We coded for this, excluding physicians' use of 
the "institutional we" as in "We usually prescribe X for this." 
 
6) Because utterances containing recommendations normally have identifiable turn-
constructional unit boundaries inviting of response, we examined whether those boundaries were 
clearly present or were, alternatively, obscured by grammatical continuations or other practices 
for turn extension. Where turn constructional unit boundaries were clear, we coded an 
"opportunity space" for response as present. The motivation for this code was to assess 
whether patient responsivity is affected by the clear presence of an opportunity space for 
response or not.  
 
7) We assessed the patient's uptake of the treatment recommendation turn as absent, 
acknowledging, nodding, accepting or resisting. We based our assessment on the first form of 
uptake in the event that there were multiple forms of uptake, and on the strength in the event that, 
for instance, nodding and verbal acceptance were done simultaneously. 
 
Covariates 
 We coded five classes of covariates: (i) national and specialty context; (ii) physician and 
patient demographic information including gender, age and race/ethnicity; (iii) type of medical 
condition (chronic, intermittent or acute, on the one hand, and existing or new, on the other 
hand); (iv) medication variables including primary class; whether the prescription was over-the-
counter vs. by prescription in the national context; and risk of addiction; and (v) outcome 
variables including diagnosis and whether the medication being recommended was ultimately 
prescribed/recommended.  
 Future studies on these data will provide more analysis of the relationship between 
covariates and interactional variables. In the present collection we focus primarily on the 
interactional dimensions of the study. 
 
This issue 
 In this volume, Stivers et al. examine the most common ways that primary care providers 
in the US and the UK recommend treatments, what conditions the use of particular treatment 
recommendation actions, and whether the actions relied on to recommend treatment are 
associated with patient uptake. They also explore the similarities and differences between the UK 
and US cases. Thompson and McCabe take us to UK Psychiatry to examine recommendation 
action and the relationship between recommendation actions and patient uptake. Toerien 
examines the use of one particular type of action, assertions, in the neurology clinic context, 
which provides a deeper analysis of the affordances of this recommendation action.  
Barnes explores where the boundary lies between pre-recommendations -- inquiries that 
are hearable as testing the waters for a treatment recommendation -- and actual treatment 
recommendations for new medications in general practice care in the UK. She asks whether 
recommendations that are preceded by pre-recommendations are different from those that are 
not, and what effect these pre-recommendations might have on patient uptake. Finally, Bergen et 
al. examine treatment resistance with an eye towards explanations for resistance that are similar 
versus at odds in the UK and the US primary care contexts.  
 This collection focuses on the treatment recommendation action and uptake, from both a 
qualitative and a quantitative perspective. We believe that this area is particularly rich with 
regard to cross-national and cross-specialty comparisons. With these studies, we hope to open up 
new areas for research that have previously been unexamined. In particular, although researchers 
have compared patients’ responses and physicians’ orientations to patient uptake following 
diagnoses and treatment recommendations and other work has identified a difference between 
positively presented recommendations for medication versus negative recommendations, our 
work is the first to explore the range of ways physicians actually positively recommend 
medications. 
 Together, the papers arising from this focused comparative study will make a substantial 
contribution to literature on doctor-patient communication, treatment decisions and shared 
decision making.  That we do this through data collected in two different healthcare systems 
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